These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 17223917)

  • 1. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.
    Chesi M; Nardini E; Brents LA; Schröck E; Ried T; Kuehl WM; Bergsagel PL
    Nat Genet; 1997 Jul; 16(3):260-4. PubMed ID: 9207791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating normal and tumor plasma cells in newly diagnosed patients of multiple myeloma and their associations with clinical and laboratory parameters.
    Gupta L; Suku P; Dash A; Bose P; Sharma P; Mallik N; Sreedharanunni S; Varma N; Jandial A; Malhotra P; Sachdeva MUS
    Curr Probl Cancer; 2024 Feb; 48():101025. PubMed ID: 37951052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics and prognosis of newly diagnosed multiple myeloma patients with FGFR3 gene mutations].
    Shen N; Zhang J; Xia Y; Shen XX; Wang J; Jin YY; Zhang R; Li JY; Chen LJ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):989-994. PubMed ID: 38503521
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitive intranuclear flow cytometric quantification of IRF4 protein in multiple myeloma and normal human hematopoietic cells.
    Vora AA; Mondala PK; Costello C; MacLeod AR; Crews LA
    STAR Protoc; 2021 Jun; 2(2):100565. PubMed ID: 34136833
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Bors A; Kozma A; Tomán Á; Őrfi Z; Kondor N; Tasnády S; Vályi-Nagy I; Reményi P; Mikala G; Andrikovics H
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma.
    Ebert LM; Vandyke K; Johan MZ; DeNichilo M; Tan LY; Myo Min KK; Weimann BM; Ebert BW; Pitson SM; Zannettino ACW; Wallington-Beddoe CT; Bonder CS
    Mol Oncol; 2022 Mar; 16(6):1221-1240. PubMed ID: 34245117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma.
    Cheong CM; Mrozik KM; Hewett DR; Bell E; Panagopoulos V; Noll JE; Licht JD; Gronthos S; Zannettino ACW; Vandyke K
    Cancer Lett; 2020 Apr; 475():99-108. PubMed ID: 32014459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressed fusion gene landscape and its impact in multiple myeloma.
    Cleynen A; Szalat R; Kemal Samur M; Robiou du Pont S; Buisson L; Boyle E; Chretien ML; Anderson K; Minvielle S; Moreau P; Attal M; Parmigiani G; Corre J; Munshi N; Avet-Loiseau H
    Nat Commun; 2017 Dec; 8(1):1893. PubMed ID: 29196615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.
    Gharbaran R
    Tumour Biol; 2016 Sep; 37(9):11573-11588. PubMed ID: 27317256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis.
    Lazareth A; Song XY; Coquin A; Harel S; Karlin L; Belhadj K; Roos-Weil D; Frenzel L; Tamburini J; Macro M; Chevret S; Loiseau HA; Minvielle S; Fermand JP; Soulier J; Bories JC; Arnulf B
    Haematologica; 2015 Nov; 100(11):e471-4. PubMed ID: 26206803
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution.
    Stewart AK; Chang H; Trudel S; Anderson KC; Richardson P; Alsina M; Reece D; Young S; Sable-Hunt A; Li Z; Keats J; Van Wier S; Ahmann G; Price-Troska T; Giusti K; Bergsagel PL; Chesi M; Fonseca R
    Leukemia; 2007 Nov; 21(11):2358-9. PubMed ID: 17568814
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts.
    Malgeri U; Baldini L; Perfetti V; Fabris S; Vignarelli MC; Colombo G; Lotti V; Compasso S; Bogni S; Lombardi L; Maiolo AT; Neri A
    Cancer Res; 2000 Aug; 60(15):4058-61. PubMed ID: 10945609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14).
    Våtsveen TK; Brenne AT; Dai HY; Waage A; Sundan A; Børset M
    Eur J Haematol; 2009 Nov; 83(5):471-6. PubMed ID: 19594619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia with a FGFR3 translocation: case report and literature review of an uncommon cytogenetic event.
    Geller MD; Pei Y; Spurgeon SE; Durum C; Leeborg NJ
    Cancer Genet; 2014; 207(7-8):340-3. PubMed ID: 25441688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome translocations in multiple myeloma.
    Bergsagel PL; Kuehl WM
    Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.
    Chandesris MO; Soulier J; Labaume S; Crinquette A; Repellini L; Chemin K; Malphettes M; Fieschi C; Asli B; Uzunhan Y; Fermand JP; Bories JC; Arnulf B
    Br J Haematol; 2007 Feb; 136(4):609-14. PubMed ID: 17223917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.
    Dring AM; Davies FE; Fenton JA; Roddam PL; Scott K; Gonzalez D; Rollinson S; Rawstron AC; Rees-Unwin KS; Li C; Munshi NC; Anderson KC; Morgan GJ
    Clin Cancer Res; 2004 Sep; 10(17):5692-701. PubMed ID: 15355895
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.